Browse studies

Find your next paid study

561 recruiting studies matching your filters

Quantitative Diffusion MRI for Prostate Cancer Detection and Monitoring

This single-center study will enroll 40 male participants to complete 2 diffusion magnetic resonance images within 30 days of each other.

Prostate Cancer

Estimated

~$10 – $750

University of California, San DiegoNCT04992728

Phase 2

Single-Arm Phase II Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

This is a single-arm Phase II clinical trial assessing the clinical efficacy of prostate specific membrane antigen (PSMA) PET/MR guided MR-LINAC based SBRT-SIB…

Prostate Cancer

Estimated

~$10 – $6,250

Weill Medical College of Cornell UniversityNCT04402151

Phase 4

Gadopiclenol (Elucirem): A New Gadolinium Based Contrast Agent With High Relaxivity for Increased Contrast and Improved Differentiation of Clinically Significant Prostate Cancer on Contrast Enhanced MRI: A Prospective Study.

The fundamental aim of this study is to show that the novel contrast agent Gadopiclenol (Elucirem), with its high relaxivity, facilitates increased contrast en…

Prostate Cancer

Estimated

~$10 – $6,250

Columbia UniversityNCT06226129

Phase 2

A Phase II Prospective 2-Arm Cohort Interventional Trial Utilizing Ultra-Hypofractionated SBRT With or Without Short Course Androgen Deprivation Therapy For Unfavorable Intermediate Risk Prostate Cancer

For this study, unfavorable intermediate risk prostate cancer patients will select whether they are to be treated with the standard of care (SOC) 6 months of A…

Prostate Cancer

Estimated

~$10 – $7,500

NYU Langone HealthNCT06397703

Phase 4

Effect of Non-steroidal Anti-inflammatory Drugs on Serum Prostate Specific Antigen Level

Prostate cancer is the most frequently diagnosed cancer in men in the Unites States. Nearly 1 million prostate biopsy procedures are performed in the United St…

Prostate CancerProstate InflammationPSA

Estimated

~$10 – $6,250

Albany Medical CollegeNCT05629494

Phase 3

(ID-COMET) A Randomized Phase III Trial of Immediate Versus Six-Month Delayed Comprehensive Treatment of 1-10 Oligometastatic Tumors With or Without Synchronous Primary

This protocol is comprised of three unblinded, randomized, single-center studies to evaluate the impact of immediate versus three-month delayed comprehensive a…

OligometastasisLung CancerColo-rectal Cancer+1 more

Estimated

~$10 – $7,500

Roswell Park Cancer InstituteNCT06563388

Phase 2

Phase II Trial of Targeted Radiation With no Castration for Mcrpc

This trial tests if the combination of comprehensive metastasis directed therapy delivered by a precision form of external beam radiotherapy (stereotactic abla…

Prostate Cancer

Estimated

~$10 – $5,625

VA Office of Research and DevelopmentNCT06084338

Phase 2

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer (VA STARPORT)

This is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed l…

Prostate CancerOligometastasisOligorecurrence+3 more

Estimated

~$10 – $5,625

VA Office of Research and DevelopmentNCT04787744

Sample Collection for Ongoing Research and Product Evaluation (SCORE) Study

The SCORE study is a prospective, multi-site clinical trial designed to collect blood and tissue samples, along with relevant clinical data, from participants …

Breast CancerLung CancerMuscle Invasive Bladder Cancer+9 more

Estimated

~$10 – $1,050

Natera, Inc.NCT07318051

Observational

Natural Language Processing-Based Feedback to Improve Physician Risk Communication and Informed Shared Decision Making in Men With Clinically Localized Prostate Cancer

The purpose of the research is to assess the impact of a natural language processing + artificial intelligence (NLP+AI)-based risk communication feedback syste…

Prostate CancerShared Decision MakingRisk Communication

Estimated

~$10 – $6,250

Cedars-Sinai Medical CenterNCT06856694

Observational

MC230504 Safe Omission of Pelvic Lymph Node Dissection (SOuND ) During Radical Prostatectomy: Diagnostic Accuracy of rhPSMA-7.3(18F) PET/CT, mpMRI and Patient Clinical Factors to Predict Lymph Node Metastasis

This clinical trial evaluates the use of an imaging scan (18F-rhPSMA-7.3 positron emission tomography \[PET\]/magnetic resonance imaging \[MRI\]) for identifyi…

Localized Prostate CarcinomaOligometastatic Prostate CarcinomaStage I Prostate Cancer AJCC v8+3 more

Estimated

~$10 – $6,250

Mayo ClinicNCT06389786

Phase 2

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)

This study aims to evaluate the role of PSMA-PET and circulating tumor DNA (ctDNA) in monitoring prostate cancer progression and response to radiotherapy (RT).…

Prostate Cancer

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT07210086